Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-19-002652)

Filing Details

Accession Number:: 0001567619-19-002652
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-07 17:06:36
Reporting Period:: 2019-02-05

Accepted Time:: 2019-02-07 17:06:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1301427	D Lawrence Kingsley	C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-05	2,405	$208.68	7,403	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average price of the shares purchased ranging from a low of $208.55 to a high of $208.88 per share. The undersigned undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.